ANIP: ANI PHARMACEUTICALS INC insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 3 sales totaling $633K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-15 | Lalwani Nikhil | CEO | $388K | yes |
| 2026-10-13 | Cook Meredith | Officer | $37K | yes |
| 2026-09-29 | Carey Stephen P. | CFO | $208K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-27 | 13G amendment | BlackRock, Inc. | 12.80% | SEC |
Institutional ownership (Q2 2026)
307 institutions reported holding $1.85B of ANI PHARMACEUTICALS INC on Form 13F (281 the quarter before). 49 opened a new position and 24 sold out. Shares held by institutions: -2%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 2,958,646 | $244.92M |
| Soleus Capital Management, L.P. | 867,760 | $71.83M |
| VANGUARD CAPITAL MANAGEMENT LLC | 838,224 | $69.39M |
| STATE STREET CORP | 831,647 | $68.86M |
| TANG CAPITAL MANAGEMENT LLC | 707,500 | $58.57M |
| DIMENSIONAL FUND ADVISORS LP | 623,463 | $51.61M |
| AMERICAN CENTURY COMPANIES INC | 574,474 | $47.55M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 562,016 | $46.52M |
| Global Alpha Capital Management Ltd. | 558,003 | $46.19M |
| GEODE CAPITAL MANAGEMENT, LLC | 536,407 | $44.41M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.